BRPI0416691A - forma de preparação farmacêutica sólida - Google Patents
forma de preparação farmacêutica sólidaInfo
- Publication number
- BRPI0416691A BRPI0416691A BRPI0416691-4A BRPI0416691A BRPI0416691A BR PI0416691 A BRPI0416691 A BR PI0416691A BR PI0416691 A BRPI0416691 A BR PI0416691A BR PI0416691 A BRPI0416691 A BR PI0416691A
- Authority
- BR
- Brazil
- Prior art keywords
- solid pharmaceutical
- pharmaceutical preparation
- preparation form
- disorders
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Abstract
"FORMA DE PREPARAçãO FARMACêUTICA SóLIDA". A presente invenção refere-se a uma forma de preparação farmacêutica sólida, contendo um ou vários excipientes e/ou adjuvantes e uma substáncia ativa do grupo dos inibidores de reabsorção do neurotransmissor monoamina com uma estrutura de tropano 2,3-dissubstituído, sua preparação e uso para a produção de um medicamento para o tratamento ou prevenção de doenças ou distúrbios nervosos centrais.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10353832A DE10353832A1 (de) | 2003-11-18 | 2003-11-18 | Feste pharmazeutische Zubereitungsform |
DE102004012045A DE102004012045A1 (de) | 2004-03-11 | 2004-03-11 | Feste pharmazeutische Zubereitungsform |
PCT/EP2004/012683 WO2005049024A2 (de) | 2003-11-18 | 2004-11-10 | Feste pharmazeutische zubereitungsform |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0416691A true BRPI0416691A (pt) | 2007-01-30 |
Family
ID=34621295
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0416691-4A BRPI0416691A (pt) | 2003-11-18 | 2004-11-10 | forma de preparação farmacêutica sólida |
Country Status (18)
Country | Link |
---|---|
US (2) | US20050124651A1 (pt) |
EP (1) | EP1686965A2 (pt) |
JP (2) | JP2007511559A (pt) |
KR (1) | KR20060125805A (pt) |
AR (1) | AR046709A1 (pt) |
AU (1) | AU2004290520A1 (pt) |
BR (1) | BRPI0416691A (pt) |
CA (1) | CA2545513C (pt) |
CO (1) | CO5690555A2 (pt) |
HK (1) | HK1094676A1 (pt) |
IL (1) | IL175246A0 (pt) |
MX (1) | MXPA06005545A (pt) |
NO (1) | NO20062810L (pt) |
NZ (1) | NZ547880A (pt) |
PE (1) | PE20050479A1 (pt) |
RU (1) | RU2377987C2 (pt) |
TW (1) | TW200529844A (pt) |
WO (1) | WO2005049024A2 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA06005545A (es) * | 2003-11-18 | 2006-08-17 | Boehringer Ingelheim Int | Preparacion farmaceutica solida. |
WO2007028769A1 (en) * | 2005-09-05 | 2007-03-15 | Neurosearch A/S | Monoamine neurotransmitter re-uptake inhibitor for neuroprotection |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61227524A (ja) * | 1985-03-30 | 1986-10-09 | Tooa Eiyoo Kk | プラゾシン製剤及びその製法 |
AU594424B2 (en) * | 1986-01-03 | 1990-03-08 | University Of Melbourne, The | Gastro-oesophageal reflux composition |
JPS62221626A (ja) * | 1986-03-20 | 1987-09-29 | Tokyo Tanabe Co Ltd | 1,4−ジヒドロピリジン化合物の製剤用組成物 |
DE3612212A1 (de) * | 1986-04-11 | 1987-10-15 | Basf Ag | Verfahren zur herstellung von festen pharmazeutischen formen |
DE3830353A1 (de) * | 1988-09-07 | 1990-03-15 | Basf Ag | Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen |
GEP20001968B (en) * | 1992-01-21 | 2000-03-05 | Glaxo Spa | Arilthio Compounds as Antibacterial and Antiviral Agents |
JPH07118154A (ja) * | 1993-10-22 | 1995-05-09 | Dainippon Pharmaceut Co Ltd | 固体分散体および粒状製剤 |
PT885220E (pt) * | 1996-02-22 | 2001-11-30 | Neurosearch As | Derivados de tropano a sua preparacao e utilizacao |
FR2762316B1 (fr) * | 1997-04-18 | 1999-12-17 | Sanofi Synthelabo | Derives de 5-aryl-3-(8-azabicyclo[3.2.1] octan-3-yl)-1,3,4- oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique |
TW580397B (en) * | 1997-05-27 | 2004-03-21 | Takeda Chemical Industries Ltd | Solid preparation |
DE60115870T3 (de) * | 2000-02-29 | 2010-07-29 | Bristol-Myers Squibb Co. | Niedrig dosierte entecavir-formulierung und deren verwendung |
KR100381834B1 (ko) * | 2000-05-20 | 2003-04-26 | 이상득 | 용출성이 개선된 프란루카스트 고체분산체 조성물 및 그제조 방법 |
WO2002102801A1 (en) * | 2001-05-23 | 2002-12-27 | Neurosearch A/S | Tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
EP1453511B1 (en) * | 2001-11-30 | 2006-11-15 | Neurosearch A/S | Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases |
ATE536874T1 (de) * | 2002-05-30 | 2011-12-15 | Neurosearch As | Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen |
EP1675591B1 (en) * | 2003-10-16 | 2011-08-10 | NeuroSearch A/S | Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor |
MXPA06005545A (es) * | 2003-11-18 | 2006-08-17 | Boehringer Ingelheim Int | Preparacion farmaceutica solida. |
CA2554617A1 (en) * | 2004-01-22 | 2005-08-04 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist |
-
2004
- 2004-11-10 MX MXPA06005545A patent/MXPA06005545A/es not_active Application Discontinuation
- 2004-11-10 RU RU2006121446/15A patent/RU2377987C2/ru not_active IP Right Cessation
- 2004-11-10 EP EP04818766A patent/EP1686965A2/de not_active Withdrawn
- 2004-11-10 KR KR1020067011982A patent/KR20060125805A/ko not_active Application Discontinuation
- 2004-11-10 JP JP2006540249A patent/JP2007511559A/ja not_active Withdrawn
- 2004-11-10 NZ NZ547880A patent/NZ547880A/en unknown
- 2004-11-10 WO PCT/EP2004/012683 patent/WO2005049024A2/de active Application Filing
- 2004-11-10 CA CA2545513A patent/CA2545513C/en not_active Expired - Fee Related
- 2004-11-10 AU AU2004290520A patent/AU2004290520A1/en not_active Abandoned
- 2004-11-10 BR BRPI0416691-4A patent/BRPI0416691A/pt not_active IP Right Cessation
- 2004-11-12 US US10/987,831 patent/US20050124651A1/en not_active Abandoned
- 2004-11-16 PE PE2004001120A patent/PE20050479A1/es not_active Application Discontinuation
- 2004-11-17 TW TW093135259A patent/TW200529844A/zh unknown
- 2004-11-17 AR ARP040104232A patent/AR046709A1/es unknown
-
2006
- 2006-04-27 IL IL175246A patent/IL175246A0/en unknown
- 2006-05-16 CO CO06046683A patent/CO5690555A2/es not_active Application Discontinuation
- 2006-06-15 NO NO20062810A patent/NO20062810L/no not_active Application Discontinuation
-
2007
- 2007-01-22 HK HK07100770.9A patent/HK1094676A1/xx not_active IP Right Cessation
-
2010
- 2010-03-24 US US12/730,831 patent/US20100178342A1/en not_active Abandoned
-
2011
- 2011-01-04 JP JP2011000224A patent/JP2011068690A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AR046709A1 (es) | 2005-12-21 |
IL175246A0 (en) | 2006-10-31 |
WO2005049024A2 (de) | 2005-06-02 |
AU2004290520A1 (en) | 2005-06-02 |
EP1686965A2 (de) | 2006-08-09 |
NO20062810L (no) | 2006-08-10 |
JP2011068690A (ja) | 2011-04-07 |
RU2006121446A (ru) | 2008-01-10 |
TW200529844A (en) | 2005-09-16 |
WO2005049024A3 (de) | 2006-03-30 |
NZ547880A (en) | 2010-02-26 |
MXPA06005545A (es) | 2006-08-17 |
HK1094676A1 (en) | 2007-04-04 |
US20050124651A1 (en) | 2005-06-09 |
CA2545513C (en) | 2013-01-08 |
JP2007511559A (ja) | 2007-05-10 |
CA2545513A1 (en) | 2005-06-02 |
US20100178342A1 (en) | 2010-07-15 |
PE20050479A1 (es) | 2005-10-06 |
RU2377987C2 (ru) | 2010-01-10 |
CO5690555A2 (es) | 2006-10-31 |
KR20060125805A (ko) | 2006-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0412054A (pt) | preparação farmacêutica transdérmica | |
CY1118179T1 (el) | Φαρμακευτικη συνθεση | |
BRPI0513300A (pt) | forma farmacêutica oral, protegida frente ao abuso, contendo (1r, 2r)-3-(3-dimetilamino-1-etil-2-propil)-fenol | |
NO20051966L (no) | Nye pyrimidinamidderivater og anvendelse derav | |
NO20080827L (no) | Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon | |
NO20062051L (no) | Farmasoytisk virkestoffinneholdende formulering med belegg | |
ATE332138T1 (de) | Flibanserin zur behandlung extrapyramidaler bewegungsstörungen | |
EA200801826A1 (ru) | Дейтерированные производные катехоламина и лекарственные средства, содержащие указанные соединения | |
CY1112376T1 (el) | Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2 | |
BRPI0512756A (pt) | composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas | |
DK1511489T3 (da) | Nye farmaceutiske sammensætninger indeholdende flibanserin-polymorf A | |
CL2009000980A1 (es) | Uso de (s)-n-(2-(1,6,8-tetrahidro-2h-inden[5,4-b]furan-8-il)etil]propionamida en combinacion con una o más drogas seleccionadas de un grupo definido para preparar un medicamento útil para la prevencion o tratamiento de la depresión o desórdenes de ansiedad (divisional de la solicitud 749-2006). | |
BRPI0411176A (pt) | combinação farmacêutica consistindo de modafinil e outra droga | |
WO2005004915A3 (en) | Compositions comprising meloxicam | |
BRPI0614197B8 (pt) | composição farmaceuticamente eficaz em uma forma farmacêutica para administração peroral contendo pelo menos um dos ingredientes ativos indometacina e acemetacina, formas de administração, e, uso da composição | |
BRPI0407438A (pt) | Sistema terapêutico compreendendo amoxicilina e ácido clavulânico | |
BRPI0416691A (pt) | forma de preparação farmacêutica sólida | |
EA200500958A1 (ru) | Дейтерированные производные катехоламина, а также лекарственные средства, содержащие эти соединения | |
AR018376A1 (es) | Composiciones farmaceuticas que se pueden dispersar de una manera espontanea y el uso de las mismas para la manufactura de un medicamento | |
SE0000303D0 (sv) | Novel compounds | |
BRPI0409170A (pt) | combinações compreendendo drogas antiepilépticas para o tratamento de distúrbios neurológicos | |
SE0203817D0 (sv) | New composition | |
BRPI0413750A (pt) | uso de loxapina ou de um seu sal farmaceuticamente aceitável, composição farmacêutica, e, kit | |
UA88284C2 (ru) | Твердая лекарственная форма, которая содержит действующее вещество из группы ингибиторов обратного захвата моноаминовых нейротрансмиттеров с 2,3-двухзамещенным тропановым скелетом, способ ее получения и применения | |
HUP0300929A2 (hu) | Fájdalomcsillapító és/vagy izomrelaxáns hatású gyógyászati készítmény |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: PARA:INT.CI. A61K 9/20, A61K 9/28, A61K 31/46, A61P 25/00 Ipc: A61K 9/20 (2011.01), A61K 9/28 (2011.01), A61K 31/ |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |